Physicians need to understand when it may be appropriate to let patients get involved in medical decision-making and when it may be necessary to provide their personal medical judgment.
The financial generosity of the pharmaceutical industry to provide funding for medical education tempts a compromise of professional standards and ethics.
In April 2002, many pharmaceutical companies adopted PhRMA code, an attempt to self-regulate the pharmaceutical industry's marketing to physicians and other health care professionals.
The AMA's Code of Medical Ethics' opinion on the use of databanks in genomic research requires informed consent by groups and individuals who are subjects of research.
An attending physician in an urban teaching hospital faces an ethical dilemma when a mother refused to allow an African American medical student to examine her child.